Tag: Health Care

LabGenomics USA
United States

LabGenomics USA Completes Acquisition of IMD CLIA Labs

October 25, 2024 – ROCKVILLE, Md. – LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This acquisition strengthens LabGenomics’ strategic development and expands its diagnostic services nationwide, particularly in molecular technology. “IMD’s molecular diagnostics program serves oncology needs in community-based hospitals. With LabGenomics USA’s financial and strategic backing, we can … Continue reading LabGenomics USA Completes Acquisition of IMD CLIA Labs

Impact Newswire
Vizient
United States

Vizient Surveys Impact of AI in Healthcare, Advancements in Pediatric Gene Therapy

IRVING, Texas – In its latest Pediatric Tech Watch, Vizient, Inc. surveys the impact of artificial intelligence (AI) in healthcare, advancements in pediatric gene therapy and rounds up the latest updates for pediatric immunizations. Read Pediatric Tech Watch. The unique needs of the pediatric population require specialized solutions. Post this “The unique needs of the pediatric population require specialized solutions,” said Sarah Herrmann, Vizient director of program services. … Continue reading Vizient Surveys Impact of AI in Healthcare, Advancements in Pediatric Gene Therapy

Impact Newswire
TruBridge
United States

TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

New Director Brings Deep Financial and Operational Expertise October 21, 2024 – MOBILE, Ala.- TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ:TBRG), a healthcare solutions company, today announced the election of Amy O’Keefe to its Board of Directors (the “Board”), effective October 18, 2024. “Amy’s deep financial experience and public company leadership spanning over three decades will be invaluable to TruBridge as we execute our growth … Continue reading TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

Impact Newswire
enGene
United States

enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

October 21, 2024 – BOSTON & MONTREAL – enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage genetic medicines company whose non-viral lead investigational product detalimogene voraplasmid (also known as detalimogene, and previously EG-70) is in an ongoing pivotal study in patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis), today announced the appointment of … Continue reading enGene Appoints Joan Connolly as Chief Technology Officer and Anthony Cheung, Ph.D., as Chief Scientific Officer

Impact Newswire
Gruppo San Donato
Europe

Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

The new company envisages the development of a network that will include a hundred structures by 2030 and will be chaired by Vito Cozzoli and led by CEO Bonifacio Moroni Press Release – The closing of the strategic agreement between San Donato Group, GKSD e Generali Italy: born Smart Clinic SpA, The company joint venture which aims to create, by 2030, a network of approximately 100 healthcare facilities across the entire Italian territory. … Continue reading Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

Impact Newswire